Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YeaRimDang Publishing | KOSDAQ | Consumer Cyclicals | Media & Publishing | KRW 68.99B | 11.7x | -0.31 | KRW 2,745 | -8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivozon Healthcare | KOSDAQ | Healthcare | Pharmaceuticals | KRW 316.94B | -63.8x | -1.3 | KRW 6,410 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Geno Focus | KOSDAQ | Basic Materials | Chemicals | KRW 101.57B | -30.2x | -0.45 | KRW 4,325 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Wonik Holdings | KOSDAQ | Technology | Semiconductors & Semiconductor Equipment | KRW 221.13B | -3.4x | 0.02 | KRW 3,195 | 10.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kyung Nam Pharm | KOSDAQ | Healthcare | Pharmaceuticals | KRW 31.39B | -1.8x | -0.02 | KRW 785 | -11% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
B2En | KOSDAQ | Technology | Software & IT Services | KRW 55.85B | -4.1x | 0.01 | KRW 1,270 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |